Nogra Pharma Limited

Gijs Van Den Brink

Francesca Viti

Daan Hommes

Auke Verhaar

The present disclosure is directed in part to heterocycles, and their use in treating medical disorders, such as immune inflammatory disorders such as Crohn's disease, ulcerative colitis, rheumatic disorders, psoriasis, and allergies. The compounds are contemplated to modulate T-Cell responses.

Heterocycles capable of modulating T-cell responses, and methods of using same

The present disclosure is directed in part to heterocycles, and their use in treating medical disorders, such as immune inflammatory disorders such as Crohn's disease, ulcerative colitis, rheumatic disorders, psoriasis, and allergies. The compounds are contemplated to modulate T-Cell responses. 

Growing community of inventors

Abcoude, Netherlands

Gijs Van Den Brink